PARM1 Antikörper (AA 201-310)

Produktnummer ABIN872651

Produktdetails anti-PARM1 Antikörper

Target: PARM1 (Prostate Androgen-Regulated Mucin-Like Protein 1 (PARM1))

Bindungsspezifität: AA 201-310

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser PARM1 Antikörper ist unkonjugiert

Applikation: ELISA, Immunocytochemistry (ICC), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Homologie: Human

Aufreinigung: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human Cipar1

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200
ICC 1:100-500

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 μg/μL

Buffer: 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.

Haltbarkeit: 12 months

Details zu PARM1

Target: PARM1 (Prostate Androgen-Regulated Mucin-Like Protein 1 (PARM1))

Andere Bezeichnung: Cipar1 (PARM1 Produkte)

Synonyme: DKFZP564O0823 antikoerper, DKFZp564O0823 antikoerper, PARM-1 antikoerper, 2210012L08Rik antikoerper, 9130213B05Rik antikoerper, W91666 antikoerper, Cipar1 antikoerper, WSC4 antikoerper, CIPAR-1 antikoerper, prostate androgen-regulated mucin-like protein 1 antikoerper, PARM1 antikoerper, Parm1 antikoerper

Hintergrund:

Synonyms: Alternative namesCastration induced prostatic apoptosis related protein 1, Cipar 1, Cipar-1, Prostatic androgen repressed message 1 protein, Protein PARM 1 Precursor,PARM1_HUMAN.

Background: Cipar1 may be involved in a survival program enabling certain prostatic cells to resist apoptosis. It is expressed in prostate and detected in other organs at low levels, these include the heart and various tissues of the urogenital tract, not detected in mammary gland.